To explore the therapeutic effect of the retinoid drug on SSc, CD4+ T cells were treated with TGF-β and/or 10 nm ATRA in the presence of anti-CD3/CD28 beads and IL-2 for 4 days in vitro. The gene discussed is TGFB1; the disease is systemic sclerosis.